DiaCarta, Inc. logo

DiaCarta, Inc.

Redefining Precision Molecular Diagnostics through Cancer Gene Mutation Detection

40 employees · est. 2012 · Pleasanton, United States

VS
IntegraGen logo

IntegraGen

Company specializing in the genomics of cancer and genetic diseases

50 employees · est. 2000 · Evry, France

IntegraGen is the older company (2012 vs 2000).

Side-by-Side Comparison

DiaCarta, Inc. IntegraGen
Founded
2012 2000 older
Headquarters
Pleasanton, United States Evry, France
Employees
40 50
Industry
Biotechnology Biotechnology, Health Care, Health and Wellness
Funding Stage
Series B Post Ipo Equity
Total Funding
$53.00M $12.40M
Funding Rounds
2 4
Services
Not tracked yet Genome Sequencing, RNA Sequencing, Methylation Analysis, Bioinformatics Analysis, NGS Sequencing, Genotyping
Target Customers
Not tracked yet Researchers, Clinicians, Academic Laboratories, Biopharmaceutical Companies, Clinical Research Organizations
Taxonomy
Precision Molecular Diagnostics, Translational Genomics, CLIA Lab, Liquid Biopsy, Cancer Mutation Detection, Colorectal Cancer Mutation Detection, In-Vitro Diagnostics, Precision Medicine, Personalized Radiation Therapy, HPV MRNA Test, Cervical Cancer Screening, Head And Neck Cancer Screening, Early Cancer Detection, NGS (Next-Generation Sequencing), SuperbDNA Technology Genomics, Cancer Research, DNA Sequencing, Precision Medicine, Bioinformatics, NGS (Next Generation Sequencing), Biomarker Testing, Clinical Interpretation, Molecular Markers, Biotech Services, Pharmaceutical Research, Rare Genetic Diseases, Metabolic Diseases, Oncology, Sequencing Services
Website
diacarta.com integragen.com
DiaCarta, Inc. logo

About DiaCarta, Inc.

DiaCarta, Inc. is a biotechnology startup that has been shaping the future of precision molecular diagnostics since its inception in 2011. The company's slogan, "Redefining Precision Molecular Diagnostics through Cancer Gene Mutation Detection," reflects its mission to revolutionize cancer diagnosis...

IntegraGen logo

About IntegraGen

IntegraGen is a France-based company specializing in the genomics of cancer and rare genetic diseases. It is a part of the OncoDNA group and boasts highly competent teams, making it a leading player in DNA sequencing services and genomic data interpretation software. The company, founded in 2000, op...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at DiaCarta, Inc. and IntegraGen — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at DiaCarta, Inc. and IntegraGen — by email.

Frequently Asked Questions

DiaCarta, Inc. — Redefining Precision Molecular Diagnostics through Cancer Gene Mutation Detection . IntegraGen — Company specializing in the genomics of cancer and genetic diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
DiaCarta, Inc. has raised $53.00M while IntegraGen has raised $12.40M.
DiaCarta, Inc. and IntegraGen operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare DiaCarta, Inc. with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy